News

Myopia: Genetic or Environmental?

by Dan Roberts Ophthalmic nearsightedness (myopia) results from an abnormal elongation of the eyeball during the growing years. This extra “axial length” causes objects at a distance to appear out of focus, which can usually be corrected with prescription glasses. The physical aspects of extreme nearsightedness (hypermyopia), however, can lead to a type of uncorrectable [Read More]

Blindness Can Be Prevented Now

Editorial by Dan Roberts, Editor-in-Chief Prevent Blindness Since 1908, Prevent Blindness has been living up to its name by educating the public about early prevention and detection. It has done this by way of vision screenings, educational programs, research support, and advocacy. But the organization hasn’t stopped there. It realizes that preventing blindness means more [Read More]

Squalamine Eye Drops Under Study for Wet AMD

(Updated 4/17/16) On June 24, 2014, Ohr Pharmaceutical, Inc. announced positive top-line interim results for its Phase 2 clinical trial of Squalamine eye drops in patients with wet age-related macular degeneration (wet AMD). The data demonstrated a positive benefit in multiple visual function including a gain in visual acuity of +10.4 letters with Squalamine eye [Read More]

StemCells, Inc. Closes Enrollment in Dry AMD Trial

Phase II Clinical Trial to Begin This Year StemCells, Inc. yesterday announced that, based on positive interim results, it has closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration (AMD) in order to focus its efforts on a follow-on Phase II randomized, controlled proof-of-concept study. Exceeding the company’s expectations, interim results showed [Read More]